Xanomeline and trospium chloride is a first-in-class medication that selectively targets the M1 and M4 receptors without blocking D2 receptors.

To provide more robust evidence for clinicians, investigators analyzed the efficacy and safety of biologics in patients with lupus nephritis using meta-regression analyses that adjusted for trials’ ...

PTC518 was granted Fast Track designation based off strong 12-month interim data on safety and efficacy.

Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions.

HealthDay News — For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according ...

Obinutuzumab, a monoclonal antibody that targets the CD20 receptor on B-cells, is currently indicated for the treatment of chronic lymphocytic leukemia and follicular lymphoma in combination with ...